Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To keep you poor
They know outsourcing wasn't in the economic plan years ago when they designed the Fed intrest rate system but they still assume our economic system is working now that Americans can know longer pay the payroll taxes the system was designed to balance.
Check out the News Room on their website, also I hopr the try for Nasdaq I got to thinking about the Amex and got a sour feeling in my stomach. The Amex stocks don't do very well IMO
http://shielddefense.com/
Did they halt trading? I saw 10,000 traded this morning and thats it.
UGHO - Yea! bang it baby! $3.00 $3.00 $3.00
ooOh yea one more time! $3.00!!!!!
UGHO - Three In A ROW
$3.00
I think an Amex listing is in the bag, question is can UGHO qualify for a Nasdaq listing?
They got that Afganistan 3 mil contract, and some sea port on the west coast I think with the government. Not sure what it's worth. Once they start announcing contracts along with an attempt to get listed this baby will fly.
The crowd is on their feet!
UGHO - Bases are loaded, heres the 3/2 pitch
Tnock! popped one high center field it's to the wall!
that ball is gone! one man scores, another runner is in!
UGHO moving up
HSTJ about to move up
NNOS waiting to move up on news
We will see a bottom when that large short of 400 million shares has to cover. Before or after the law suit, I can wait. LOL Ive been holding HPON for years.
Anyone in NNOS?
UGHO is still on track according to the website http://shielddefense.com/
check out this bit on OurStreet posted by another poster.
http://ragingbull.lycos.com/mboard/boards.cgi?board=UGHO&read=7971
Here is a last meal for the bashers
http://ragingbull.lycos.com/mboard/boards.cgi?board=UGHO&read=7971
If they lost their contract which it doesn't appear that they have because todays visit to their website looks upgraded from last week when I visited whats up? Is the competition doing everything they can to bash UGHO because it looks dam impressive to me. The below is fired from their gun or launcher this is not the flash light. - Sky
------------------------------------------------------
ChemBall™
Non-lethal Projectiles
Debilitating Pava Powder Chemical is discharged from the patented ChemBall frangible non-lethal projectile…
Instant Pain, Respiratory Distress, Severe Eye-tearing and Intense Burning Skin Sensation on impact as ChemBall strikes and disperses an atomized cloud of Pava!
Shield Defense ChemBall Non-lethal Projectiles use several chemical agents in its non-lethal munitions offering law enforcement and military fill choices of CS, OC, CS/OC, and CN agents.
Impacting at 15-19 ft. lbs. of pressure ChemBall's cause substantial distress, but will not generally cause damage to vital organs.
Delivery by December 2004.
http://www.shielddefense.com/
Almost 30 million burgers sold today!
That will be a major seller. But the one that will eat Tasers lunch is the Pistol that fires multiple rounds that explode at 19 foot pounds on impact releasing a agent that renders the suspect or attacker helpless until he can be handcuffed. The projectiles are patented by the US Navy. This along with the light ontop as backup will be the top seller. Yhe ultimate crowd control weapon that will change the way people think about the taking of another life. Eventually criminals won't be using life threating means because the police are not. It will take time to create this mind set but it can happen.
I hope the company sells some stock to get cash positive then take us to the Amex or Nasdaq!
You don't know what you are talking about so get lost. one trick pony
Forgot to mention private security firms that don't allow their officers to carry real weapons only mace should be some of the big contracts for this. Think about it a Taser in a crowd is bad news for the person using the Taser or walking a beat at night. The crime doesn't wait for you to get with in range for a perfect shot. Another example a foot patrol hears a rape in progress and chases the perp he can't shoot him in the back with a real gun or get a good shot with a Taser but he can fire several rounds the hit the perp with 20 pound blast of agent if nothing else the perp will turn around to see what in the hell is this guy or gal shooting at me, it's something out of a comic book, energy blast going off knocking me too my ass, I give up! IMO
The pistol projectile launcher with a stun light would out perform the Taser in ammo and range. Think about it it seems almost every person Tasered there were two officers at the seen they get close enough to talk to the suspect get a little closer so that they don't miss then zap!!! electriction. Would the Taser work if they confronted a street gang? Hell no! Would an officer with one multi fire projectile pistol with a back up stun light work with the projectiles knocking each suspect off their feet hell yea! IMO
This stock will knock you off your feet, literally!
Security Stocks are the Next Growth Stocks
I think they forgot where Taser started, on the OTC
They should add these to their list, UGHO & HSTJ - Sky
----------------------------------------------------
http://www.forbes.com/investmentnewsletters/2004/09/17/cz_kr_0917soapbox.html?partner=yahoo&refe....
Adviser Soapbox
Don't Fall For Taser Wannabes
Kenneth Reid, Spear's Security Industry Analyst, 09.17.04, 2:05 PM ET
It is a truism that markets run on fear and greed, but according to Mark Douglas, author of Trading in the Zone, greed is simply a disguised version of another fear, the fear of missing out.
Magnify your profits with stock options. Click here for our new FREE weekly Forbes/Schaeffer's Options Report.
So, naturally, when we witness the periodic mini-manias in micro-cap homeland-security stocks such as MACE (nasdaq: MACE - news - people ) and Digital Recorders (nasdaq: TBUS - news - people )--both of which were up substantially this week--it may create a painful fantasy about missing out on the next Taser, and lead, perhaps, to some impulsive, but ill-advised stock purchases to medicate that pain. Sadly, two wrongs won't make it right.
It usually takes a real news catalyst to spark the speculative fire in secondary homeland-security companies, however, the announcement by Taser (nasdaq: TASR - news - people ) on Wednesday of a retail version of its non-lethal personal protection device--"Citizen Defense System"--and the subsequent unexpected authorization by British Home Secretary David Blunkett of the TASER M26 for use by police forces throughout England and Wales fit the bill.
The latter development was a nasty surprise for those who love to hate this stock (79% of the 19 million-share float is sold short), particularly after Taser president and co-founder Thomas Smith downplayed the possibility of major third-quarter international orders at the Morgan Keegan Equity Conference last week. This piece of good news caused an intraday trading halt and more electrifying drama for the shares of the $1 billion market cap company.
---------------------------------------------------------
Special Offer: With homeland security and counter-terrorism spending on the rise, security stocks are the new growth stocks. For a list of stocks to buy now, click here for the latest issue of Spear's Security Industry Analyst.
------------------------------------------------------------
Professional traders, however, seek an edge away from the headlines and rarely buy the news. Instead, if the story is compelling, they look for proxies--direct or indirect. That's when the secondary security names can skyrocket, particularly if the float (shares available to trade) is small, market makers are few, and momentum day traders with 4-times margin get on board for their daily dose of adrenaline.
With no intention to disparage particular companies, one indispensable key to a good long-term investment is institutional sponsorship---the "I" in Bill O'Neil's CANSLIM method. Together, MACE and Digital Recorders appear to have less than 500,000 shares held by institutions, hardly a sign of long-term commitment by professional investors. MACE, which is touting its security cameras, still gets 90% of its cash flow from declining car wash operations and Digital Recorders, which is promoting its new vehicle tracking equipment, recently reported soft quarterly revenue and continuing quarterly and annual losses.
So far this year, like Icarus of Greek mythology, all of the secondary security plays have levitated briefly only to fall back into the quiescent sea of anonymity. It is doubtful that this time it will be any different. The holders of bid-up shares are renting a ride, not owning a company. A buy-and-hold attitude at this altitude will leave you holding the bag. If you seek short-term excitement in trading, these names can provide it. If you seek investment-grade companies in homeland security, look elsewhere.
Special Offer: The Forbes Investors Advisory Institute just published a 12-page report to help investors prepare for the fall election season and beyond. Click here for top adviser stock picks in this FREE Financial Roundtable report.
For smart surveillance on the new frontier, consider Verint (nasdaq: VRNT - news - people ), which on Wednesday reported $60 million in quarterly sales, up 28% year-over-year. The company specializes in video equipment that captures and analyzes images according to specific behavioral criteria. This week, Verint announced the acquisition of RP Security, a privately held German firm whose technology has been developed specifically for the transportation security market. Verint has a small enough float (5.7 million) to spark momentum if share demand increases, 38% institutional ownership, which is enough to lend some price stability, and a sufficient base of installed customers--more than 1,000 both corporate and government in 50 countries--to drive recurring revenue and new product interest.
By the way, we still like Taser, despite its high valuation, and recommend a "buy" on a pullback to the $35 area. The company owns its niche, which we believe will eventually become a compelling worldwide franchise, but it is not stopping there. They are developing, with General Dynamics (nyse: GD - news - people ), wireless, piezoelectric taser-like bullets, which we suspect will be a hot item in the brave new world of global homeland insecurity. In short, the next Taser is still Taser.
Kenneth Reid maintains no long or short positions in any of the stocks mentioned above.
For more information and to subscribe to Spear's Security Industry Analyst, click here.
More Adviser Soapbox Columns
Send comments and questions to newsletters@forbes.com.
The news on DFIB is so fresh they haven't even issued a press release yet. Their last press release was 8/26/04.
These guys, manufacture, sell, and put others names on their product.
Keep an eye on DFIB long term hold to $10 - $20 IMO do ur DD
----------------------------------------------
MSNBC.com
Home defibrillator without prescription OK'd
FDA approves device for use in cases of sudden cardiac arrest
The Associated Press
Updated: 3:18 p.m. ET Sept. 16, 2004
WASHINGTON - The Food and Drug Administration decided Thursday that consumers can buy devices to jump-start failing hearts at home without a prescription. Some 80 percent of sudden cardiac arrests occur at home.
Before the agency's decision, consumers who wanted a HeartStart home defibrillator to use in those crucial minutes before an ambulance arrived needed a doctor's prescription.
The FDA endorsed a July recommendation from its advisory panel to remove the prescription requirement after federal advisers were satisfied that consumers could use the machines safely.
Higher survival rate
Sudden cardiac arrest differs from a heart attack in that it's an electrical malfunction of the heart that triggers fatally abnormal heart rhythm. Often, it's the first hint of heart disease and accounts for roughly 340,000 deaths outside of health care settings each year.
The shock from a defibrillator is the most effective way to end sudden cardiac arrest, which leaves the victim breathing abnormally and unresponsive. HeartStart delivers a jolt of energy equivalent to what it takes to illuminate a 150-watt light bulb for one second.
When the shock is delivered within five minutes of the sudden cardiac arrest, 50 percent of individuals survive, said Deborah DiSanzo, vice president and general manager of cardiac resuscitation at Philips Medical Systems, manufacturer of the device.
Ambulances typically arrive within nine minutes of a 911 call. Ten minutes after the sudden cardiac arrest, the patient has a 1 percent chance of survival, she said.
The division, part of Andover, Mass.-based Philips Electronics North America, said it has sold more than 6,000 devices from November 2002, when the FDA first approved their use, through Sept. 15, 2004.
Waiving prescriptions could raise sales beyond 20,000 per year, a volume high enough to cut a few hundred dollars from the $1,995 price tag, DiSanzo said.
Device 'safe for consumers to use'
Dr. Graham Nichol, chair of the American Heart Association's automated external defibrillator task force, surveyed scientific journals published since 1966.
"There are no reports to suggest these devices are unsafe. Furthermore, there is no evidence the prescription requirement increases safety," Nichol said. "It's essentially a medical device that is safe for consumers to use."
Still, because of the lack of "sufficient scientific data," the association said it could not endorse or caution against use of the devices in homes.
"Will lives be saved? Lives have already been saved," Nichol said. But he added that it's not clear how many "or how many will be in the future."
Dr. Arthur Kellermann, chairman of the department of emergency medicine at Emory School of Medicine, in Atlanta, said he had "substantial reservations" about the FDA's actions.
"We have no scientific evidence to support the decision and I don't think that's a good way to make health policy," Kellermann said.
Opponents argue that families with average risk of sudden cardiac arrest could reduce survival chances by wasting precious time looking for a defibrillator gathering dust, rather than calling an ambulance.
Kellermann called the devices "very expensive lottery tickets" since there is "a remote possibility" an individual family may save a life by owning one.
© 2004 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
URL: http://www.msnbc.msn.com/id/6020916/
MRIs double rates of breast cancer detection, ultrasounds less useful: study
Cassandra Szklarski
Canadian Press
Tuesday, September 14, 2004
TORONTO (CP) - MRI scans detect breast cancer at twice the rate of traditional screening procedures, says a Canadian-led study that suggests only the most at-risk women consider the costly procedure because of its tremendous false positive rate. Researchers also looked at the usefulness of ultrasounds and found little advantage to traditional mammography tests. However, when combined, varied screening methods detected tumours that individual methods simply could not find on their own, says lead researcher Dr. Ellen Warner of Toronto's Sunnybrook Regional Cancer Centre. Of the four possible screening methods, magnetic resonance imaging is more accurate than mammography, ultrasound or clinical breast exams. "If you can only do one (test), MRI is the best," Warner said Tuesday of her findings, to be published Wednesday in the Journal of the American Medical Association. "We're not telling (women) to go out and do it, we're just saying that this picks up more cancers at an earlier stage. Whether it's going to make them live longer, we don't know yet." Earlier detection can, however, help some women avoid chemotherapy or even mastectomies because when tumours are found early, they're most treatable, said Warner. The study considered only those most at risk for cancer - those carrying either the BRCA1 or BRCA2 mutation genes. The average woman, and even those who may have a family history of breast cancer, is not a candidate for MRI testing because of its high false positive rate - up to 50 per cent, said Warner. Labour-intensive ultrasounds, growing in use to screen women with dense breasts, appeared to detect cases that mammography could not but produced about the same number of false positives as MRIs, causing unnecessary biopsies, Warner said. "Is it worth all those extra biopsies and time costs to detect a few extra cancers? Maybe not," she said. Her study looked at 236 women aged 25 to 65, between November 1997 and March 2003. Using the four screening methods, researchers found 22 cancers - 17 of them detected by MRI. That was more than twice the rate of mammography, which detected eight cancers, and ultrasound tests, which found seven. The breast exams found two cases. Combined, however, all four screening methods appeared to miss just one, compared to the 12 missed by the traditional screenings of mammography and breast exams combined. On later review, the missing cancer case was in fact detected by the MRI, Warner said. High-risk women over the age of 25 are currently advised to have a mammogram annually and a clinical breast examination every six months; however, many tumours are detected at a relatively advanced stage. Warner said a day may come when MRIs are recommended as routine screening, but the risks today make it hard to justify, even for high-risk candidates with faulty genes. " 'If it might work, do it,' is what a lot of people would say," about using MRI scans that cost in the range of $1,200 at private clinics or $600 at Sunnybrook, said Warner. "But with our Canadian health-care system, can we afford to invest a ton of money into something that might not be useful?" Warner said women who fear they may carry the faulty genes can find out for sure by getting an information booklet and tape from the Canadian Cancer Society. They can also consult their family doctor to see if they should be referred to a special genetics clinic. The Sunnybrook findings echo those of a Dutch study released in July that also suggested MRI scans find nearly twice as many tumours as mammograms in high-risk women but also gave more false alarms. That study, published in the New England Journal of Medicine, looked at women with faulty genes but also those with a strong family history of breast cancer. The American Cancer Society recommends that women at high risk consider having an MRI plus mammography but not in place of it, because mammography found some cancers that MRI missed. In Canada, an estimated 21,200 cases were discovered last year and an estimated 5,300 women died from the disease. Interestingly, Warner noted that the Dutch researchers were rarely able to detect non-invasive cancer with MRI scans, finding them instead through mammography. Canadians on the other hand, spotted non-invasive cases with MRIs presumably due to more experience with the technology. "Our radiologists just got better at it," Warner said. "We had some training. We had some people visiting from the States, we learned what it looked like."
© The Canadian Press 2004
http://www.canada.com/health/story.html?id=1c91b4dc-bc0d-4d04-ac2e-cb110c10ecbe
You know, what if they asked all shareholders to mail in a Notorized copy of their trade confirmations?
It would be just like at tax time
Har! ROTFLMAO I think he wants us to sellllllllllll must be from RB they want people on that board to call in their certificates. Claiming that he who has his certs. in hand first is garunteed to be legit. What a bunch of BS If you paid cash and got a trade confirmation you are guarnteed through your broker that they are yours. Nice try goof balls.
Anyone got a naked short share trade confirmation that says you own the shares? didn't think so
Ha Ha! Algorim.. Agorramim... Agortimmims...?
LOL, I wish a hurakin would get up under my NNOS stock.
I have nick named it "Ivan the Terrible"
Mr. Blum
"He is also experienced in these areas: 1) plan funding through institutional banking and Wall Street sources and through sale, acquisition and merger"
http://www.google.com/url?sa=U&start=1&q=http://www.becker-poliakoff.com/attorneys/bios/blum....
Whew! it took a lot of reading just to find one line of reorgaization stuff. Man ill bet this guy has seen tons of office equiptment go to liquidation auction I wonder if he can get me a flat screen monitor? LOL -Sky
The words... each NNOS shareholder will recieve ___ shares,
"In addition to" the shares that they hold.
The share price fears the words "In exchange for"
Imminent Breakout - didn't Nicholas Cage star in that?
Cool! looks like NNOS will be the FRY's of Health care services
Fry's is the meg-lo mart of electronics, Kitchen appliances, computers, computer services, TV's, office furniture, every laptop made, cameras, movies & CD's, Circuit boards & accessories, you name it they got it. The Macy's of consummer goods.
Looks like NNOS will be the talk
of the Medical Services Sector
I think the deal might have been started back then but due to who will own what they finally sealed the deal, maybe.
Or It could be as it reads Scott Ervin bought intrest back then and NNOS bought all of it, maybe.
we will see
Micro Bio-Medical Waste Systems Inc.(OTC BB:MBWS)
Scott A. Ervin, president and CEO
Ten percent of each stand alone company, thats a heck of a dividend.
Boston Business Journal - May 5, 2004
http://boston.bizjournals.com/boston/stories/2004/05/03/daily24.html
LATEST NEWS
May 5, 2004
Haverhill Technologies sold to Las Vegas company
Boston Business Journal
Las Vegas-based Micro Bio-Medical Systems Inc. has reached a preliminary agreement to acquire Haverhill Technologies Group Inc., a builder of industrial vacuum furnace equipment.
The companies did not disclose financial terms of the agreement. Haverhill has $3 million in annual revenue and $13 million in assets, Micro Bio-Medical reported.
Haverhill's furnaces start at $35,000, and upper-end models are designed to heat to 3,000 degrees celsius and pressurize to 1,500 pounds per square inch.
Micro Bio-Medical Waste Systems Inc. disposes medical waste for health care and life science organizations. Its vehicles dump waste into hermetically sealed hoppers where it is shredded, super-heated with steam and microwave beams, then mixed into silica and lime. The company then sells the substance as a recycled material.
© 2004 American City Business Journals Inc.
Web reprint information
All contents of this site © American City Business Journals Inc. All rights reserved.
Sounds good. What kind of dividend?